Elicio Therapeutics to Host Virtual KOL Event on November 11
Elicio Therapeutics plans a virtual key opinion leader event about ELI-002 7P for metastatic and neoadjuvant pancreatic cancer.
Elicio Therapeutics plans a virtual key opinion leader event about ELI-002 7P for metastatic and neoadjuvant pancreatic cancer.